GOOG Stock DD Google, Inc. 08/05/2014 16:49:58

New Post Public Reply Private Reply Replies (0) Message Board

Aug 5, 2014 at 5:50 PM

GOOG Google, Inc. $GOOG Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=GOOG&...mp;yt0=Go!

Last Updated: 08/05/2014 16:49:53

Current Price and Quotes
Last Price 565.07
Previous Close 573.15 Open 570.05
Daily Range 562.61 - 571.98 52wk Range 502.80 - 604.83
Volume 1,551,223 Dividend N/A
Average Vol (3m) 1,700,282 Yield N/A

Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 59,825,000 50,175,000 37,905,000 29,321,000
Cost of Revenue 25,858,000 20,634,000 13,188,000 10,417,000
Gross Profit 33,967,000 29,541,000 24,717,000 18,904,000
Operating Expenses

Research and Development 7,952,000 6,793,000 5,162,000 3,762,000
Sales, General and Admin. 12,049,000 9,988,000 7,813,000 4,761,000
Non-Recurring Items - - - -
Other - - - -
Operating Income 13,966,000 12,760,000 11,742,000 10,381,000
Income From Continuing Operations

Add'l Income/Expense Items 530,000 626,000 584,000 415,000
Earnings Before Interest and Tax 14,496,000 13,386,000 12,326,000 10,796,000
Interest Expense - - - -
Earnings Before Tax 14,496,000 13,386,000 12,326,000 10,796,000
Income Tax 2,282,000 2,598,000 2,589,000 2,291,000
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 12,214,000 10,788,000 9,737,000 8,505,000
Non Recurring Events

Discontinued Operations 706,000 (51,000) - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 12,920,000 10,737,000 9,737,000 8,505,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 12,920,000 10,737,000 9,737,000 8,505,000

Recent News

Aug 5, 2014 Critical Alerts For VoxelJet, Google, Orexigen Therapeutics, Illumina, and Activision Blizzard Released By InvestorsObserver
Aug 4, 2014 Consumer Interest for Next Generation Smart Devices Rapidly Increases Via Social Media Initiatives - Celebrity Social Media Campaign Focuses on Newest Secure Smart Wallet
Jul 31, 2014 Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet
Jul 31, 2014 Illumina Appoints Jeff Huber to its Board of Directors
Jul 30, 2014 S&P Dow Jones Indices Announces Treatment of Stock Dividend for Discovery Communications in S&P 500
Jul 25, 2014 Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency
Jul 23, 2014 Appointments, Financial Results, Space-Themed Attractions, and Technical Updates - Research Reports on Google, Yahoo, Baidu, TripAdvisor and Yandex
Jul 23, 2014 Aggressive Marketing Campaigns Increase Major Awareness for Latest Smart Technology Advancements - Newest Smart Wallet To Be Featured During Television Shows
Jul 22, 2014 Anchorage bus routes arrive on Google Maps
Jul 22, 2014 Post-Earnings Coverage: Google

1
2
3
4
5
6
7
8
next >

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Drives Major Time Savings in Endoscopy Tech

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...